OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

Por de Souza, MS, Trichavaroj, R, Schuetz, A, Chuenarom, W, Phuang-ngem, Y, Jongrakthaitae, S, Ratto-Kim, S, Nitayaphan, S, Dally, L, Rerks-Ngam, S, Tartaglia, J, Francis, D, Michael, NL, Paris, RM, Kim, JH
Publicado em 2009